Spine Biologics Update
09 Juli 2008 - 9:00AM
UK Regulatory
RNS Number : 6207Y
Arthro Kinetics plc
09 July 2008
Progress Update - Biologics for Spine
WEDNESDAY, 9th July 2008 - Arthro Kinetics plc (AIM: AKI) ("Arthro Kinetics" or the "Company"), the orthopedics company dedicated to
regenerating joint mobility and spinal disc function provides an update to its spinal development program.
Following an extensive program of biomechanical testing Arthro Kinetics' lead nucleus replacement product has successfully attained all
of its in-vitro and safety goals and will now enter pre-clinical studies in the second half of 2008. If successful, the Company expects to
initiate a first in man study for this implant in early 2009.
This internal program also provided the foundation for the discovery of a novel, proprietary annulus closure device. Arthro Kinetics has
filed patent applications for this innovative device, which though highly complementary to the nucleus replacement product, is of itself a
significant new opportunity for Arthro Kinetics. The Company expects this device to enter human studies in 2009.
In 2007 Arthro Kinetics began the development of its novel, proprietary collagen matrix for use as a nucleus replacement (of the
intervertebral disc of the spine). The nucleus replacement implant aims to provide a solution for degenerative disc disease which is more
effective than pain management but significantly less invasive than current decompression procedures such as fusion. As with other Arthro
Kinetics' products under development the focus is on treating patients early in order to prevent further degeneration and pain.
CONTACTS
Arthro Kinetics Plc Tel: +49 (0)711 305 110 70
Jason Loveridge, Chief Executive Officer
Doug Quinn, Chief Financial Officer
Nomura Code Securities Limited Tel: +44 (0)207 776 1200
Richard Potts
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUWRNRWWRBRAR
Arthro Kinetics (LSE:AKI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Arthro Kinetics (LSE:AKI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Arthro Kinetics (Londoner Börse): 0 Nachrichtenartikel
Weitere Arthro Kinetics Plc News-Artikel